AAO-HNS GUIDELINES Bundle (free trial)

Adult Sinusitis

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1012340

Contents of this Issue

Navigation

Page 5 of 11

Treatment Table 3. Summary of Key Action Statements (KAS) Statement Action Strength 1a. Differential diagnosis Clinicians should distinguish presumed ABRS from ARS caused by viral upper respiratory infections and noninfectious conditions. A clinician should diagnose ABRS when (a) symptoms or signs of ARS (purulent nasal drainage accompanied by nasal obstruction, facial pain-pressure-fullness, or both) persist without evidence of improvement for ≥10 days beyond the onset of upper respiratory symptoms, or (b) symptoms or signs of ARS worsen within 10 days aer an initial improvement (double worsening ). S-B 1b. Radiographic imaging and ARS Clinicians should NOT obtain radiographic imaging for patients who meet diagnostic criteria for ARS, unless a complication or alternative diagnosis is suspected. R-B against 2. Symptomatic relief of VRS Clinicians may recommend analgesics, topical intranasal steroids, and/or nasal saline irrigation for symptomatic relief of VRS. O-B/C 3. Symptomatic relief of ABRS Clinicians may recommend analgesics, topical intranasal steroids, and/or nasal saline irrigation for symptomatic relief of ABRS. O-A, B, D 4. Initial management of ABRS Clinicians should either offer watchful waiting a (without antibiotics) or prescribe initial antibiotic therapy for adults with uncomplicated ABRS. Watchful waiting should be offered only when there is assurance of follow-up, such that antibiotic therapy is started if the patient's condition fails to improve by 7 days aer ABRS diagnosis or if it worsens at any time. R-A 5. Choice of antibiotic for ABRS b If a decision is made to treat ABRS with an antibiotic agent, the clinician should prescribe amoxicillin with or without clavulanate as first-line therapy for 5-10 days for most adults. R-A 6. Treatment failure for ABRS If the patient worsens or fails to improve with the initial management option by 7 days aer diagnosis or worsens during the initial management, the clinician should reassess the patient to confirm ABRS, exclude other causes of illness, and detect complications. If ABRS is confirmed in the patient initially managed with observation, the clinician should begin antibiotic therapy. If the patient was initially managed with an antibiotic, the clinician should change the antibiotic. R-B Note: Surgical management of CRS is not discussed in this guideline because of insufficient evidence (e.g., randomized controlled trials) for evidence-based recommendations.

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Adult Sinusitis